MRP Capital Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

MRP Capital Investments’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.89M	Sell	3,810 -115	-3%	-$51K	1.4%	23
2026 Q1	$1.75M	Buy	3,925 +3,921	+98,025%	+$1.83M	1.53%	25
2025 Q4	$1.77K	Sell	4 -3,571	-100%	-$1.54M	﹤0.01%	189
2025 Q3	$1.59M	Sell	3,575 -900	-20%	-$376K	1.37%	26
2025 Q2	$1.99M	Buy	4,475 +395	+10%	+$182K	1.37%	20
2025 Q1	$1.98M	Buy	4,080 +160	+4%	+$74.6K	1.85%	13
2024 Q4	$1.58M	Buy	3,920 +190	+5%	+$88.1K	1.44%	20
2024 Q3	$1.73M	Buy	3,730 +50	+1%	+$24K	1.65%	18
2024 Q2	$1.72M	Sell	3,680 -345	-9%	-$150K	1.61%	17
2024 Q1	$1.68M	Buy	4,025 +647	+19%	+$274K	1.69%	19
2023 Q4	$1.37M	Sell	3,378 -2,490	-42%	-$920K	1.48%	22
2023 Q3	$936K	Buy	5,868 +3,290	+128%	+$1.15M	1.04%	36
2023 Q2	$907K	Buy	+2,578	New	+$869K	0.89%	38

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

MRP Capital Investments's VRTX Position: Q2 2026 in Review

MRP Capital Investments reduced its Vertex Pharmaceuticals (VRTX) stake by 2.9% in Q2 2026, selling an estimated $51K and leaving 3,810 shares worth $1.89M. The position accounts for 1.4% of the portfolio, ranked #23.

MRP Capital Investments first reported a position in VRTX in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.99M in Q2 2025. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

MRP Capital Investments held 3,810 shares of Vertex Pharmaceuticals worth $1.89M as of Q2 2026.
MRP Capital Investments sold 115 Vertex Pharmaceuticals shares in Q2 2026, an estimated $51K.
Vertex Pharmaceuticals made up 1.4% of MRP Capital Investments's portfolio in Q2 2026, its #23 holding.
MRP Capital Investments first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
MRP Capital Investments's Vertex Pharmaceuticals position peaked at $1.99M in Q2 2025.
1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on MRP Capital Investments's 13F filing for Q2 2026, filed 10 Aug 2026.